Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.94 USD | 0.00% | -1.01% | +12.25% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 03 | Oppenheimer Upgrades Aldeyra Therapeutics to Outperform From Perform, $10 Price Target | MT |
Financials (USD)
Sales 2024 * | 28.43M | Sales 2025 * | 22.31M | Capitalization | 234M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | -23M | EV / Sales 2024 * | 8.23 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.5 x |
P/E ratio 2024 * |
-78.8
x | P/E ratio 2025 * |
-10.4
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.39% |
Latest transcript on Aldeyra Therapeutics, Inc.
1 week | -1.01% | ||
Current month | +20.49% | ||
1 month | +36.81% | ||
3 months | +29.61% | ||
6 months | +154.19% | ||
Current year | +12.25% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 05-08-31 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 09-04-30 |
Martin Joyce
BRD | Director/Board Member | 70 | 13-09-30 |
Ben Bronstein
BRD | Director/Board Member | 74 | 10-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.94 | 0.00% | 462,606 |
24-04-24 | 3.94 | +0.77% | 570,606 |
24-04-23 | 3.91 | -0.51% | 452,310 |
24-04-22 | 3.93 | +1.81% | 372,085 |
24-04-19 | 3.86 | -3.02% | 429,655 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.25% | 234M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.70% | 22.02B | |
-17.84% | 20.9B | |
-9.26% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- ALDX Stock